National Wealth Management Group »

Fs Global Cr Opportunitie Fda shares owned by National Wealth Management Group

Quarter-by-quarter ownership of Fs Global Cr Opportunitie Fda (FSCO) shares owned by National Wealth Management Group from 13F filings

Historical chart of National Wealth Management Group investment in Fs Global Cr Opportunitie Fda

Tip: Access up to 7 years of quarterly data

All positions including Fs Global Cr Opportunitie Fda held by National Wealth Management Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fs Global Cr Opportunitie Fda by National Wealth Management Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $94k 16k 5.93
2023-12-31 $90k 16k 5.67
2023-09-30 $91k 17k 5.42
2023-06-30 $94k 18k 5.08
2023-03-31 $292k 68k 4.29
2022-12-31 $583k 124k 4.71

More positions owned by National Wealth Management Group

T Rowe Price Etf Price Blue Chip (TCHP)
T Rowe Price Etf Cap Appreciation (TCAF)
Capital Group Intl Focus Eqt Shs Creation Uni (CGXU)
Schwab Strategic Tr Sht Tm Us Tres (SCHO)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Amazon (AMZN)
Ishares Tr Core S&p500 Etf (IVV)
Invesco Exch Traded Fd Tr Ii Nasdaq 100 Etf (QQQM)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Spdr Ser Tr Bloomberg 1-3 Mo (BIL)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Meta Platforms Cl A (META)
Pacer Fds Tr Us Cash Cows 100 (COWZ)

View all positions for National Wealth Management Group

Top funds holding Fs Global Cr Opportunitie Fda

Commonwealth Equity Services
Nomura Holdings
Cambridge Investment Research Advisors
Thomas J. Herzfeld Advisors
Sit Investment Associates
Wagner Wealth Management
Cetera Investment Advisers
LPL Financial
Penserra Capital Management
Envestnet Asset Management
H D Vest Advisory Services
Advisor Group Holdings
Rockefeller Capital Management
Saba Capital Management
Morgan Stanley

View all funds holding Fs Global Cr Opportunitie Fda